Skip to main content
Patient preference and adherence logoLink to Patient preference and adherence
. 2018 Jul 27;12:1347–1354. doi: 10.2147/PPA.S162892

Health-related quality of life in elderly diabetic outpatients in Vietnam

Huong Thi Thu Nguyen 1,2,, Mackenzie PI Moir 3, Thanh Xuan Nguyen 2,4, Anh Phuong Vu 5, Long Hoang Luong 2,4, Tam Ngoc Nguyen 1,2, Long Hoang Nguyen 6, Bach Xuan Tran 7,8, Tung Thanh Tran 9, Carl A Latkin 8, Melvyn WB Zhang 10, Roger CM Ho 11, Huyen Thanh Thi Vu 1,2
PMCID: PMC6067618  PMID: 30100711

Abstract

Background

Health-related quality of life (HRQoL) is an important indicator for designing care and treatment services for patients with diabetes. This is especially true given its rapid increase among the elderly population in Vietnam. HRQoL data in elderly diabetic Vietnamese are currently limited. This study aimed to 1) measure the HRQoL of elderly patients with type 2 diabetes (T2DM) in Vietnam and 2) identify related factors and their relationship with HRQoL.

Patients and methods

A cross-sectional study was conducted. We recruited 171 patients aged ≥60 years with T2DM at the Outpatient Department, National Geriatric Hospital from June to November 2015. Patients were asked to evaluate their health status using the EuroQol Five Dimensions Three Levels (EQ-5D-3L) and the Visual Analog Scale (VAS). Sociodemographic, diabetic treatment, and management characteristics were collected. Multivariate Tobit regression was used to determine which factors were associated with HRQoL, and the strength of this relationship.

Results

Patients reported some problems in all areas of the EQ-5D: pain/discomfort (50.9%), mobility (33.3%), anxiety/depression (24.0%), usual activities (21.1%), and self-care (10.5%). The mean EQ-5D index score was 0.80 (SD=0.20), and the mean EQ-VAS was 57.5 (SD=14.4). Patients who were male, lived in an urban area, could afford treatment, were taking fewer medications, and monitored blood pressure often (1–4 times a week) had a higher EQ-5D index when compared to other groups. Meanwhile, a longer duration of diabetes and older age were negatively associated with the EQ-5D index. Patients with any comorbidity had lower VAS scores than their counterparts.

Conclusion

The presence of diabetes and comorbidity were responsible for a significant decrease in HRQoL. Screening and identifying health problems, providing prompt treatment, and facilitating self-management among patients have the potential to increase diabetic patients’ HRQoL.

Keywords: elder, quality of life, diabetes, Vietnam

Introduction

Population aging is an emerging problem of priority on the global health care policy agenda.1 The aging of the Vietnamese population has been accelerating in recent years, with substantial increases in the elderly population (aged ≥60 years) in both relative and absolute numbers.1 It is estimated that the percentage of elder people will rise to over 30% in 2050 from 8.9% in 2009.1,2 Ensuring sufficient care and treatment provision as well as social supports for this population has become a major challenge to the Vietnam Government.3,4

Health-related quality of life (HRQoL) is considered an important indicator of health issues and health care needs in the elderly.57 Information about HRQoL can also be used to evaluate the performance of health care services, particularly when the availability of administrative data is limited.7,8 It can also be used to economically evaluate the effectiveness of health technologies and treatment.7,9 HRQoL data are therefore needed in order to develop interventions and conditions favorable to the promotion of HRQoL.

Diabetes is increasingly common in low- and middle-income countries such as Vietnam. It is estimated that in 2015, over 3.5 million Vietnamese adults were living with diabetes.10 The prevalence of diabetes is especially high among the elderly. Pham and Eggleston showed that 12.8% of males and 10.9% of females living in Thai Nguyen over the age of 60 years had diabetes.11 Type 2 diabetes mellitus (T2DM) is the most common form of metabolic disorder in Vietnam, with a prevalence that has doubled in the previous decade (2.7% in 2002 to 5.4% 2012).12,13 T2DM is disproportionally prevalent in different geographic regions throughout Vietnam.14,15 For example, in 2008, the rate of diabetes was more than 11% in Ho Chi Minh City, which is the biggest city in Vietnam,16 but less than 1% in rural Vietnam.17

Most patients with T2DM in Vietnam receive care on an outpatient basis, with hospital visitation used for regular physical assessment and management of complications. Elderly T2DM patients often suffer from comorbidities and geriatric syndromes that contribute to the development of frailty, defined as the cumulative decline of multiple physiological functions (eg, muscle weakness, low gait speed, etc.).18,19 The combination of diabetes and comorbidity can increase the likelihood of adverse outcomes, such as falls, disability, death, and hospitalization,19,20 all of which can significantly impair a patient’s quality of life.2123 Moreover, geriatric syndromes are a major obstacle when providing treatment and care to diabetic patients.18,22,24 Therefore, it is necessary to investigate the HRQoL of these patients, and associated factors, so that interventions designed to improve HRQoL can be developed and deployed.

Evaluations of HRQoL in elderly diabetic populations have been conducted worldwide in Asia,25,26 Europe,2730 and the USA.31 Determinants of HRQoL have been found to vary across studies. Most have found correlations between HRQoL and sex, age, capacity to pay for treatment, occupations, income, body mass index (BMI), comorbidities (cardiovascular diseases, neuropathy, etc.), and treatment modalities like insulin or exercise.25,27,28,30,32 However, few evaluations of HRQoL in diabetic populations have been completed in resource-scarce settings like Vietnam. Therefore, the objective of this study was to measure the HRQoL of elderly patients with T2DM in Vietnam and identify its covariates.

Patients and methods

Study design

A cross-sectional study was conducted from July to November 2015 at the Outpatient Department, National Geriatric Hospital. A convenience sampling approach was used to recruit patients. To participate in the study, all subjects had to be 1) aged 60 years and older, 2) diagnosed with diabetes according to diagnostic criteria set out by the International Diabetes Federation in 2013, 3) undergoing treatment as an outpatient at the National Geriatric Hospital, and 4) able to communicate with the data collector. Patients were excluded if 1) they were unable to complete the questionnaire and 2) they refused to participate in the study. A sample of 171 patients was recruited.

Measures and instruments

A structured questionnaire was developed and used for 25-min face-to-face interviews. Data collectors were students who were enrolling in undergraduate medical doctor and nursing degrees at Hanoi Medical University. To avoid social desirability bias, we did not use physicians and nurses employed at the hospital research site for collecting data. We conducted several training sessions for data collectors to ensure that they asked questions consistently and obtained high-quality data. The questionnaire included the following variables.

Primary outcomes

HRQoL was measured using EuroQol Five Dimensions Three Levels (EQ-5D-3L),25 which consists of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three levels of responses: level 1; no problems; level 2: some problems; level 3: extreme problems. Health states were converted into a weighted index by applying scores from the UK utility tariffs set due to the unavailability of a Vietnamese tariff.33 The EQ-5D index score ranged from −0.594 to 1, with a higher index depicting better HRQoL.33 We also employed the EQ Visual Analog Scale (EQ-VAS) to record the participant’s self-rated health on a vertical scale that ranges from 0 to 100. Zero represents the worst health state a patient can imagine and 100 represents the best health state a patient can imagine.

Covariates

Sociodemographic and behavior characteristics included age, sex (male/female), education attainment that was classified into three categories (low education: lower high school; medium education: graduate high school; high education: tertiary education), living location (urban/rural), people living with family/relatives/others/alone, who their primary informal caregiver was (family/relatives/others/none), the ability to pay for treatment (yes/no), smoking status (yes/no), and if they were a current alcohol user (yes/no).

We measured the weight and height of participants to calculate their BMI. We used three BMI categories: <18.50 kg/m2 (underweight), 18.5–24.99 kg/m2 (normal), and ≥25.00 kg/m2 (overweight/obesity). Moreover, information on comorbidities was given by patients’ self-reported data and confirmed by investigator based on medical records and medication utilization.

We also collected data on patients’ diabetes treatment characteristics such as their disease duration, treatment modality (oral antidiabetic drug, insulin, both or doing exercise only), number of medicines, whether they forgot to take medicine in the last 4 weeks (yes/no), fasting plasma glucose (mmol/L), and HbA1c (%) level. Glycemic goals for adults with diabetes were achievement of fasting plasma glucose ≤7.2 mmol/L and HbA1c <7%.34 Other characteristics such as self-monitoring of blood glucose at home (yes/no), frequency of blood pressure monitoring and exercises, diet modification (yes/no), and if patients had ever delayed an examination were also collected.

Data analysis

Data analysis was performed using STATA 12.0 software (Stata Corp. LP, College Station, TX, USA). First, we described variables by using frequency and percentage for categorical variables, and mean and standard deviation for continuous variables. Multivariate regression was used to identify the factors associated with the EQ-5D index and EQ-VAS. Because the outcome data were censored data, we employed Tobit regression (or censored regression) model to have better estimation compared to typical linear regression. Stepwise forward selection strategies were used to produce the reduced model. These strategies selected variables into the final models using the threshold of p-value at 0.2 for the log-likelihood ratio test. Statistical significance was defined as any p-value less than 0.05.

Ethics approval and informed consent

The study was approved by the National Geriatric Hospital Research Ethics Committee (No 794 NGH IRB). Written informed consent, which was approved by the Research Ethics Committee of the National Geriatric Hospital, Hanoi, Vietnam, was obtained from all participants in this study prior to data collection.

Results

Among 171 patients, the mean age was 69.4 years (SD=6.8). The majority of the patients were females (58.5%), had a medium education (35.1%), lived in an urban area (94.7%), and lived with family (93.6%). Most of them were taken care by their families (94.2%) and were able to pay for diabetes treatment (81.9%). In addition, 93% of patients had comorbidities. The mean EQ-5D index was 0.80 (SD=0.20), and the mean EQ-VAS was 57.5 (SD=14.4) (Table 1).

Table 1.

Socioeconomic and behavior characteristics of respondents

n Percentage
Total 171 100.0
Sex, female 100 58.5
Education attainment
 Low education 57 33.4
 Medium education 60 35.1
 High education 54 31.6
Living location
 Urban area 162 94.7
 Rural area 9 5.3
Living with
 Family 160 93.6
 Alone 7 4.1
 Others 4 2.3
Being taken care by
 Family 161 94.2
 Other people 6 3.5
 None 4 2.3
Able to pay diabetes treatment 140 81.9
Have health insurance 170 99.4
Smoking 38 22.2
Alcohol use 138 80.7
Comorbidities
 Yes 159 93.0
 No 12 7.0
Body mass index categories
 Underweight 5 2.9
 Normal 138 80.7
 Overweight/obesity 28 16.4

Mean SD

Age (years) 69.4 6.8
EQ-5D index 0.80 0.20
VAS 57.5 14.4

Abbreviations: EQ-5D, EuroQol Five Dimensions; VAS, Visual Analog Scale.

Table 2 depicts that most of the patients had a diagnosis that was over 10 years old (49.1%). The most common treatment modality was oral medications (50.3%). More than five oral prescriptions were prescribed to 45.6% of patients for diabetes mellitus or other comorbidities. The average fasting plasma glucose was 7.8 mmol/L (SD=2.2) and HbA1c was 7.1% (SD=1.5%).

Table 2.

Treatment characteristics among respondents

n Percentage
Duration of diabetes
 <1 year 7 4.1
 1–5 years 35 20.5
 6–10 years 45 26.3
 >10 years 84 49.1
Treatment therapy
 OAD 86 50.3
 Insulin 25 14.6
 OAD and insulin 56 32.7
 None 4 2.4
Number of medicines
 <3 28 16.4
 3–5 65 38.0
 >5 78 45.6

Mean SD

Fasting plasma glucose (mmol/L) 7.7 2.2
HbA1c (%) 7.1 1.5

Abbreviation: OAD, oral anti-diabetic drug.

Self-management of respondents is shown in Table 3. Most respondents performed self-monitoring blood glucose at home (69.0%), modified their diet (86.6%), and always did their exercises (77.8%), whereas 42.7% always monitored their blood pressure at home. Only 3.5% of patients delayed their examinations and 17.0% forgot to take their medication in the last 4 weeks (Table 3).

Table 3.

Diabetes self-management of respondents

n Percentage
Self-monitoring blood glucose at home
 Yes 118 69.0
 No 53 31.0
Frequency of blood pressure monitor
 Always (5 times per week or more) 73 42.7
 Often (1–4 times per week) 42 24.6
 Rarely (1–3 times per month) 44 25.7
 Never 12 7.0
Diet modification
 Yes 148 86.6
 No 23 13.5
Frequency of doing physical exercises
 5 times per week or more 133 77.8
 1–4 times per week 12 7.0
 1–3 times per month 11 6.4
 Never 15 8.8
Ever delayed examination
 Yes 6 3.5
 No 165 96.5
Forgot to take medicine
 Yes 29 17.0
 No 142 83.0

Figure 1 shows the HRQoL status of participants described with the five dimensions of the EQ-5D-3L. One-third of the sample had some problems (level 2) in mobility (33.3%), whereas 50.9% and 24.0% had some problems in pain/discomfort and anxiety/depression, respectively. About 81.3% of individuals were able to do daily activities in the last 2 weeks and 81.3% patients felt tired in the last 7 days.

Figure 1.

Figure 1

HRQoL of participants described with the EQ-5D-3L instrument.

Abbreviations: HRQoL, health-related quality of life; EQ-5D-3L, EuroQol Five Dimensions Three Levels.

Figure 2 shows the mean VAS score based on age group. The group aged 60–64 years had the highest mean VAS score: 60.1 (SD=13.2).

Figure 2.

Figure 2

Mean EQ-VAS score for age groups.

Abbreviation: EQ-VAS, EuroQol Visual Analog Scale.

Table 4 presents the factors associated with HRQoL among diabetic patients. In terms of EQ-5D index, patients who were male, living in an urban area, could afford treatment, were taking fewer medications, and often monitored their blood pressure (1–4 times/week) had a higher EQ-5D index compared to others. Meanwhile, higher duration of diabetes and older age were negatively associated with the EQ-5D index. Participants who had any comorbidities had lower VAS scores than their counterparts. Those living in urban areas and taking 3–5 drugs had higher VAS score than those living in rural settings and taking more than 5 drugs, respectively.

Table 4.

Factors associated with HRQoL among diabetic patients

EQ-5D index
VAS
Coef 95% CI Coef 95% CI
Sex (male vs female) 0.22* 0.11; 0.34 4.80 −0.40; 10.01
Age −0.01* −0.02; −0.00
Living location (urban vs rural) 0.33* 0.13; 0.54 12.13* 1.28; 22.98
Afford diabetic treatment (yes vs no) 0.16* 0.01; 0.30
Duration of diabetes (vs <1 year)
 6–10 years −0.14* −0.25; −0.02
Treatment modalities (vs none)
Insulin −0.12 −0.26; 0.01 −6.71 −13.87; 0.45
Number of drugs used (vs >5 drugs)
 <3 drugs 0.23* 0.08; 0.38 5.19 −2.22; 12.59
 3–5 drugs 0.19* 0.07; 0.30 9.77* 4.14; 15.39
Self-monitoring blood glucose at home (yes vs no) 0.07 −0.04; 0.19
Having comorbidities (yes vs no) −10.16* −19.00; −1.33
Frequency of doing exercises (vs none)
 1–4 times/week 0.14 −0.05; 0.33
Forgot to take medicine (no vs yes) 0.16 −0.07; 0.39
Frequency of monitoring blood pressure (vs none)
 1–4 times/week 0.21* 0.07; 0.34

Note:

*

p<0.05.

Abbreviations: HRQoL, health-related quality of life; EQ-5D, EuroQol Five Dimensions; VAS, Visual Analog Scale; CI, confidence interval.

Discussion

Our study was among the first research offering needed insights about the HRQoL of elderly Vietnamese with T2DM. In this study, we found that elderly patients with T2DM had a lower EQ-5D index and VAS score when compared to the general elderly Vietnamese population.35 This result was also lower than HRQoL of elderly patients with diabetes in Korea36 and India,37 but higher than that in Saudi Arabia.38 Moreover, our elderly diabetic patients reported substantially high rates of having problems in pain/discomfort, mobility, and anxiety/depression, which align with other studies on Asian populations.21,36,39,40

After using multivariate regressions to adjust for sociodemographic characteristics, our results showed that those suffering from comorbidities were more likely to report lower HRQoL, being consistent with worldwide studies.26,27,30,41,42 In our cohort, we observed that hypertension and dyslipidemia were the most common comorbidities. Our results also demonstrated that polypharmacy was associated with lower HRQoL. Multiple drugs were often prescribed to patients to manage their T2DM (ie, insulin, anti-hypoglycemic drugs, etc.), comorbid conditions, and related complications. Over-prescription and polypharmacy pose increased risk of adverse drug reactions in the elderly due to physiological changes that result in impaired drug metabolism and excretion.43

In addition, we also found that higher duration of diabetes was found to have a significantly negative association with patients’ HRQoL, which is consistent with some previous studies.39,44 Geriatric syndromes, increasing age, and T2DM often require some forms of long-term management and treatment of sequelae, which may compound in those with a longer disease duration.45,46 In middle- to low-income countries like Vietnam, management of these chronic conditions places a heavy socioeconomic and emotional burden on both patients and their families.4749 It is likely that our decreased HRQoL in those with a longer disease duration is a combination of compounding comorbidity and complications along with the impact of socioeconomic and emotional burden.

In this study, we found that people with insulin treatment had lower HRQoL compared to those not using any therapies; however, the association was insignificant. Lu et al found that both insulin and oral agent use were associated with lower EQ-5D index scores.44 In addition, Luk et al found that insulin use was associated with higher EQ-5D index, but with a lower VAS score,39 whereas other work has found that treatment therapies had no impact on HRQoL.21,40,50 The lower HRQoL in insulin-treated patients is likely explained by the suffering associated with a heavier burden in patients with more advanced disease, along with the diverse set of complications that come with it.41 The difference between our study and other previous studies may be due to the smaller sample size and more advanced age of our cohort. Moreover, Maatouk et al suggested that insulin injections might carry lower stigma in the elderly than in younger adults.30 In addition, the lower HRQoL could be caused by the pain of multiple daily insulin injections and the patients’ beliefs that taking insulin means the diabetes is worse and the patient has failed.51 Therefore, this finding points the need of educational counseling programs for insulin-treated patients from the health staff.

Self-monitoring of blood glucose and hypertension are common home management practices among elderly patients. In this study, we found that frequent monitoring of blood pressure was positively associated with higher HRQoL. Hypertension is both a complication and risk factor of diabetes.13 This illness is also a risk factor of other diseases such as stroke and cardiovascular diseases.52 Self-monitoring is associated with improved self-care and better treatment compliance, leading to the improvement of health status and HRQoL in patients with chronic diseases.31,53

This study has several implications. First, providers of patients with longer disease duration are cognizant of the increased burden faced by those with advanced disease. Interventions focused on improving psychological and emotional wellbeing may improve the HRQoL of patients by addressing important illness and burden-related concerns more common to advanced disease. Second, health care providers should provide education to patients about the importance and effectiveness of self-management practices, such as regular blood pressure and blood glucose monitoring. Moreover, the role of the family in supporting patients in being successful in the self-management of their disease, thereby slowing its advancement, should also be emphasized. Finally, larger future studies should be conducted to fill in the gaps about the HRQoL impact of insulin-related complications among Vietnamese diabetic patients.

There were several limitations to this study. First, its cross-sectional design restricts the drawing of causal relationships between HRQoL and potential associated factors. Second, our use of convenience sampling limits the generalizability of our study to other hospital settings. The effects of recall bias in our data, due to the use of mainly self-reported data, further limit our results.

Conclusion

Our study is the first examination of the HRQoL among elderly diabetic patients in Vietnam. Significant decreases in reported HRQoL were related to disease duration, comor-bidity, treatment modality, and self-management practices. Screening and identifying health problems in these patients, as well as providing prompt treatment and facilitating self-management, offer low-cost solutions to improving HRQoL in a resource-scarce setting.

Acknowledgments

The authors gratefully appreciate Ms Dinh Kim Dung and Ms Dao Thi Huyen for helping to recruit patients for this study.

Footnotes

Disclosure

The authors report no conflicts of interest in this work.

References

  • 1.World Health Organization World Report on Ageing and Health. 2015. [Accessed November 18, 2017]. Available form: http://www.who.int/ageing/events/world-report-2015-launch/en/
  • 2.General Statistics Office of Vietnam . Major findings: the 1/4/2015 time-point population change and family planning. Hanoi: General Statistics Office of Vietnam; 2016. [Google Scholar]
  • 3.Bussarawan T, Long GT. Socioeconomic status and health among older adults in Vietnam, 2001–2011. XXVII IUSSP International Population Conference; August 26–31, 2013; Busan, Republic of Korea. [Google Scholar]
  • 4.Huong NT, Ha LTH, Tien TQ. Determinants of health-related quality of life among elderly: evidence from Chi Linh Town, Vietnam. Asia Pac J Public Health. 2017;29(5_suppl):84S–93S. doi: 10.1177/1010539517704041. [DOI] [PubMed] [Google Scholar]
  • 5.George PP, Heng BH, De Castro Molina JA, Wong LY, Wei Lin NC, Cheah JT. Self-reported chronic diseases and health status and health service utilization – results from a community health survey in Singapore. Int J Equity Health. 2012;11:44. doi: 10.1186/1475-9276-11-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Toan NV, Trong LN, Höjer B, Persson LA. Public health services use in a mountainous area, Vietnam: implications for health for policy. Scand J Public Health. 2002;30(2):86–93. doi: 10.1080/14034940210133780. [DOI] [PubMed] [Google Scholar]
  • 7.Kruk ME, Freedman LP. Assessing health system performance in developing countries: a review of the literature. Health Policy. 2008;85(3):263–276. doi: 10.1016/j.healthpol.2007.09.003. [DOI] [PubMed] [Google Scholar]
  • 8.Giang KB, Allebeck P. Self-reported illness and use of health services in a rural district of Vietnam: findings from an epidemiological field laboratory. Scand J Public Health Suppl. 2003;62:52–58. doi: 10.1080/14034950310015112. [DOI] [PubMed] [Google Scholar]
  • 9.Ravens-Sieberer U. Measuring and monitoring quality-of-life in population surveys: still a challenge for public health research. Soz Praventivmed. 2002;47(4):203–204. doi: 10.1007/BF01326397. [DOI] [PubMed] [Google Scholar]
  • 10.International Diabetes Federation IDF Diabetes Atlas. Seventh Edition. 2015. [Accessed September 23, 2017]. Available from: http://www.diabetesatlas.org/component/attachments/?task=download&id=116.
  • 11.Pham NM, Eggleston K. Prevalence and determinants of diabetes and pre-diabetes among Vietnamese adults. Diabetes Res Clin Pract. 2016;113:116–124. doi: 10.1016/j.diabres.2015.12.009. [DOI] [PubMed] [Google Scholar]
  • 12.Khue NT. Diabetes in Vietnam. Ann Glob Health. 2015;81(6):870–873. doi: 10.1016/j.aogh.2016.01.003. [DOI] [PubMed] [Google Scholar]
  • 13.Nguyen CT, Pham NM, Lee AH, Binns CW. Prevalence of and risk factors for type 2 diabetes mellitus in Vietnam: a systematic review. Asia Pac J Public Health. 2015;27(6):588–600. doi: 10.1177/1010539515595860. [DOI] [PubMed] [Google Scholar]
  • 14.Duc Son le NT, Hanh TT, Kusama K, et al. Anthropometric characteristics, dietary patterns and risk of type 2 diabetes mellitus in Vietnam. J Am Coll Nutr. 2005;24(4):229–234. doi: 10.1080/07315724.2005.10719469. [DOI] [PubMed] [Google Scholar]
  • 15.Khan NC, Khoi HH. Double burden of malnutrition: the Vietnamese perspective. Asia Pac J Clin Nutr. 2008;17(Suppl 1):116–118. [PubMed] [Google Scholar]
  • 16.Ta MT, Nguyen KT, Nguyen ND, Campbell LV, Nguyen TV. Identification of undiagnosed type 2 diabetes by systolic blood pressure and waist-to-hip ratio. Diabetologia. 2010;53(10):2139–2146. doi: 10.1007/s00125-010-1841-6. [DOI] [PubMed] [Google Scholar]
  • 17.Mwangi J, Kulane A, Van Hoi L. Chronic diseases among the elderly in a rural Vietnam: prevalence, associated socio-demographic factors and healthcare expenditures. Int J Equity Health. 2015;14:134. doi: 10.1186/s12939-015-0266-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Paolisso G. Pathophysiology of diabetes in elderly people. Acta Biomed. 2010;81(Suppl 1):47–53. [PubMed] [Google Scholar]
  • 19.Kesavadev JD, Short KR, Nair KS. Diabetes in old age: an emerging epidemic. J Assoc Physicians India. 2003;51:1083–1094. [PubMed] [Google Scholar]
  • 20.Croxson SC, Price DE, Burden M, Jagger C, Burden AC. The mortality of elderly people with diabetes. Diabet Med. 1994;11(3):250–252. doi: 10.1111/j.1464-5491.1994.tb00267.x. [DOI] [PubMed] [Google Scholar]
  • 21.Choi YJ, Lee MS, An SY, et al. The relationship between diabetes mellitus and health-related quality of life in Korean adults: the Fourth Korea National Health and Nutrition Examination Survey (2007–2009) Diabetes Metab J. 2011;35(6):587–594. doi: 10.4093/dmj.2011.35.6.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kanauchi M, Kubo A, Kanauchi K, Saito Y. Frailty, health-related quality of life and mental well-being in older adults with cardiometabolic risk factors. Int J Clin Pract. 2008;62(9):1447–1451. doi: 10.1111/j.1742-1241.2008.01830.x. [DOI] [PubMed] [Google Scholar]
  • 23.Lin CC, Li CI, Chang CK, et al. Reduced health-related quality of life in elders with frailty: a cross-sectional study of community-dwelling elders in Taiwan. PLoS One. 2011;6(7):e21841. doi: 10.1371/journal.pone.0021841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Nezu S, Okamoto N, Morikawa M, et al. Health-related quality of life (HRQOL) decreases independently of chronic conditions and geriatric syndromes in older adults with diabetes: the Fujiwara-kyo Study. J Epidemiol. 2014;24(4):259–266. doi: 10.2188/jea.JE20130131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Tang WL, Wang YM, Du WM, Cheng NN, Chen BY. Assessment of quality of life and relevant factors in elderly diabetic patients in the Shanghai community. Pharmacoepidemiol Drug Saf. 2006;15(2):123–130. doi: 10.1002/pds.1166. [DOI] [PubMed] [Google Scholar]
  • 26.Ghassemzadeh R, Nasseh H, Arastoo AA, Kamali M, Rahimi Foroushani A, Arzaghi M. Quality of life in elderly diabetic: comparison between home and nursing home. Acta Med Iran. 2013;51(4):254–259. [PubMed] [Google Scholar]
  • 27.Trief PM, Wade MJ, Pine D, Weinstock RS. A comparison of health-related quality of life of elderly and younger insulin-treated adults with diabetes. Age Ageing. 2003;32(6):613–618. doi: 10.1093/ageing/afg105. [DOI] [PubMed] [Google Scholar]
  • 28.Ausili D, Bulgheroni M, Ballatore P, et al. Self-care, quality of life and clinical outcomes of type 2 diabetes patients: an observational cross-sectional study. Acta Diabetol. 2017;54(11):1001–1008. doi: 10.1007/s00592-017-1035-5. [DOI] [PubMed] [Google Scholar]
  • 29.Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017;8(4):120–129. doi: 10.4239/wjd.v8.i4.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Maatouk I, Wild B, Wesche D, et al. Temporal predictors of health-related quality of life in elderly people with diabetes: results of a German cohort study. PLoS One. 2012;7(1):e31088. doi: 10.1371/journal.pone.0031088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gilden JL, Casia C, Hendryx M, Singh SP. Effects of self-monitoring of blood glucose on quality of life in elderly diabetic patients. J Am Geriatr Soc. 1990;38(5):511–515. doi: 10.1111/j.1532-5415.1990.tb02399.x. [DOI] [PubMed] [Google Scholar]
  • 32.Brown DW, Balluz LS, Giles WH, et al. Behavioral Risk Factor Surveillance System (BRFSS) Diabetes mellitus and health-related quality of life among older adults. Findings from the behavioral risk factor surveillance system (BRFSS) Diabetes Res Clin Pract. 2004;65(2):105–115. doi: 10.1016/j.diabres.2003.11.014. [DOI] [PubMed] [Google Scholar]
  • 33.Group E EQ-5D-3L User Guide: Basic information on how to use the EQ-5D-3L instrument. 2015. [Accessed January 6, 2017]. Available from: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-3L_UserGuide_2015.pdf.
  • 34.American Diabetes Association Standards of medical care in diabetes – 2017. Diabetes Care. 2017;40(1):48–57. [Google Scholar]
  • 35.Bang KS, Tak SH, Oh J, Yi J, Yu SY, Trung TQ. Health status and the demand for healthcare among the elderly in the rural Quoc-Oai District of Hanoi in Vietnam. Biomed Res Int. 2017;2017:4830968. doi: 10.1155/2017/4830968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lee WJ, Song KH, Noh JH, Choi YJ, Jo MW. Health-related quality of life using the EuroQol 5D questionnaire in Korean patients with type 2 diabetes. J Korean Med Sci. 2012;27(3):255–260. doi: 10.3346/jkms.2012.27.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Singh K, Kondal D, Shivashankar R, et al. Health-related quality of life variations by sociodemographic factors and chronic conditions in three metropolitan cities of South Asia: the CARRS study. BMJ Open. 2017;7(10):e018424. doi: 10.1136/bmjopen-2017-018424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Al-Aboudi IS, Hassali MA, Shafie AA. Knowledge, attitudes, and quality of life of type 2 diabetes patients in Riyadh, Saudi Arabia. J Pharm Bioallied Sci. 2016;8(3):195–202. doi: 10.4103/0975-7406.171683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Luk AOY, Zhang Y, Ko GTC, et al. Health-related quality of life in Chinese patients with type 2 diabetes: an analysis of the Joint Asia Diabetes Evaluation (JADE) Program. J Diabetes Metab. 2014;5:333. [Google Scholar]
  • 40.Sakamaki H, Ikeda S, Ikegami N, et al. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health. 2006;9(1):47–53. doi: 10.1111/j.1524-4733.2006.00080.x. [DOI] [PubMed] [Google Scholar]
  • 41.Wändell PE, Tovi J. The quality of life of elderly diabetic patients. J Diabetes Complications. 2000;14(1):25–30. doi: 10.1016/s1056-8727(99)00066-5. [DOI] [PubMed] [Google Scholar]
  • 42.Sakurai T, Iimuro S, Sakamaki K, et al. Japanese Elderly Diabetes Intervention Trial Study Group Risk factors for a 6-year decline in physical disability and functional limitations among elderly people with type 2 diabetes in the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2012;12(Suppl 1):117–126. doi: 10.1111/j.1447-0594.2011.00819.x. [DOI] [PubMed] [Google Scholar]
  • 43.Milton JC, Hill-Smith I, Jackson SH. Prescribing for older people. BMJ. 2008;336(7644):606–609. doi: 10.1136/bmj.39503.424653.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lu Y, Wang N, Chen Y, et al. Health-related quality of life in type-2 diabetes patients: a cross-sectional study in East China. BMC Endocr Disord. 2017;17(1):38. doi: 10.1186/s12902-017-0187-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Li MZ, Ji LN, Meng ZL, et al. Management status of type 2 diabetes mellitus in tertiary hospitals in Beijing: gap between guideline and reality. Chin Med J (Engl) 2012;125(23):4185–4189. [PubMed] [Google Scholar]
  • 46.Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO. Managing type 2 diabetes: going beyond glycemic control. J Manag Care Pharm. 2008;14(5 Suppl B):s2–s19. [PubMed] [Google Scholar]
  • 47.Gallacher K, May CR, Montori VM, Mair FS. Understanding patients’ experiences of treatment burden in chronic heart failure using normalization process theory. Ann Fam Med. 2011;9(3):235–243. doi: 10.1370/afm.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sav A, Salehi A, Mair FS, McMillan SS. Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature. BMC Med Res Methodol. 2017;17(1):140. doi: 10.1186/s12874-017-0411-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sav A, King MA, Whitty JA, et al. Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expect. 2015;18(3):312–324. doi: 10.1111/hex.12046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Mayberry LS, Osborn CY. Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care. 2012;35(6):1239–1245. doi: 10.2337/dc11-2103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Fremantle N, Blonde L, Duhot D, et al. Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes. Diabetes Care. 2005;28(2):427–428. doi: 10.2337/diacare.28.2.427. [DOI] [PubMed] [Google Scholar]
  • 52.World Health Organization Hypertension. 2017. [Accessed November 18, 2017]. Available from: http://www.who.int/topics/hypertension/en/
  • 53.Watts FN. Behavioural aspects of the management of diabetes mellitus: education, self-care and metabolic control. Behav Res Ther. 1980;18(3):171–180. doi: 10.1016/0005-7967(80)90034-0. [DOI] [PubMed] [Google Scholar]

Articles from Patient preference and adherence are provided here courtesy of Dove Press

RESOURCES